Aurantiamide
Aurantiamide is a non-covalent, orally active, blood-brain-permeable GRPR selective antagonist with anti-inflammatory and neuroprotective effects. Aurantiamide reduces inflammation and oxidative stress in renal tissue by inhibiting GRPR-mediated renal necrosis pathways (such as RIPK3/MLKL signaling) and NF-κB inflammatory pathways, exerting anti-acute kidney injury and endothelial function activities. Aurantiamide also inhibits the M1 polarization of microglia and inhibits NLRP3 activation, thereby improving AD mouse models. Aurantiamide has in vivo inhibitory efficacy in acute kidney injury models such as ischemia/reperfusion, sepsis, and hypertension models[1][2][3][4][5].
Product Specifications
CAS Number
58115-31-4
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Mixed Lineage Kinase; NF-κB; RIP kinase
Type
Natural Products
Related Pathways
Apoptosis; MAPK/ERK Pathway; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/aurantiamide.html
Purity
99.56
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](CO)CC1=CC=CC=C1)[C@@H](NC(C2=CC=CC=C2)=O)CC3=CC=CC=C3
Molecular Formula
C25H26N2O3
Molecular Weight
402.49
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
NF-κB; RIPK3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse Monoclonal MORF4 Antibody (OTI5F2) [Alexa Fluor 532]
